Below are the most recent publications written about "Quality of Life" by people in Profiles.
-
Mallya SG, Upadhyay A, Psoter KJ, Case MA, Vest MT, Putcha N, Hansel NN, Eakin MN. Association between Difficulty Affording Medications and Outcomes in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2025 07; 22(7):984-991.
-
Freedland SJ, Mulhall JP, Gleave M, De Giorgi U, Saad F, Rannikko A, Ivanova JI, Nasr AF, Reisman AL, Ganguli A, Kral P, Turnbull J, Shore N. Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study. Eur Urol. 2025 05; 87(5):507-511.
-
Basch E, Schrag D, Jansen J, Henson S, Ginos B, Stover AM, Carr P, Spears PA, Jonsson M, Deal AM, Bennett AV, Thanarajasingam G, Rogak L, Reeve BB, Snyder C, Bruner D, Cella D, Kottschade LA, Perlmutter J, Geoghegan C, Given B, Mazza GL, Miller R, Strasser JF, Zylla DM, Weiss A, Blinder VS, Wolf AP, Dueck AC. Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial. Nat Med. 2025 Apr; 31(4):1225-1232.
-
Poiset SJ, Lombardo J, Castillo E, Castillo R, Jones B, Miften M, Kavanagh B, Dicker AP, Boyle C, Simone NL, Movsas B, Grills I, Rusthoven CG, Vinogradskiy Y, Wilson L. Patient-Reported Outcomes: Comparing Functional Avoidance and Standard Thoracic Radiation Therapy in Lung Cancer. JCO Clin Cancer Inform. 2025 02; 9:e2400202.
-
Hark LA, Gorroochurn P, Tang H, Torres DR, Blackburn B, Maruri SC, Diamond DF, Harizman N, Wang Q, Wang Y, Liebmann JM, Cioffi GA, Horowitz JD, Park L. Improvement in vision-related quality-of-life using the NEI-VFQ-9 over 1-year in the Manhattan Vision Screening and Follow-up Study (NYC-SIGHT). Graefes Arch Clin Exp Ophthalmol. 2025 Jul; 263(7):2069-2079.
-
Cowan E, O'Brien-Lambert C, Eiting E, Bull E, Ryder J, Calderon Y, Salsitz E. Emergency department-initiated oral naltrexone for patients with moderate to severe alcohol use disorder: A pilot feasibility study. Acad Emerg Med. 2025 05; 32(5):488-497.
-
Holtan SG, Bola?os-Meade J, Al Malki MM, Wu J, Kitko CL, Reshef R, Rezvani AR, Shaffer BC, Solh MM, Yao JM, Runaas L, Elmariah H, Larkin KT, El Jurdi N, Gooptu M, Loren AW, Hall AC, Alousi AM, Jamy O, Clark W, Kean L, Bhatt AS, Perales MA, Applegate K, Efebera YA, Leifer E, Jones RJ, Horowitz MM, Mattila D, Saber W, Hamadani M, Martens MJ. Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703. J Clin Oncol. 2025 03 10; 43(8):912-918.
-
Jonassaint CR, Lalama CM, Carroll CP, Badawy SM, Hamm ME, Stinson JN, Lalloo C, Saraf SL, Gordeuk VR, Cronin RM, Shah N, Lanzkron SM, Liles D, O'Brien JA, Trimnell C, Bailey L, Lawrence RH, Saint Jean L, DeBaun M, De Castro LM, Palermo TM, Abebe KZ. Digital cognitive behavioral therapy vs education for pain in adults with sickle cell disease. Blood Adv. 2024 Dec 24; 8(24):6257-6266.
-
Sina EM, Rowe M, Mancuso G, Garber G, Kelly WK, Leader AE. Evaluating the Impact of a Novel Program to Address Acute Food Insecurity Among Cancer Patients. Nutrients. 2024 Dec 23; 16(24).
-
Regnault A, Bunod L, Loubert A, Brose MS, Hess LM, Maeda P, Lin Y, Speck RM, Gilligan AM, Payakachat N. Assessing tolerability with the Functional Assessment of Cancer Therapy item GP5: psychometric evidence from LIBRETTO-531, a phase 3 trial of selpercatinib in medullary thyroid cancer. J Patient Rep Outcomes. 2024 12 19; 8(1):149.